Company's DSU Products offer biologically safer water through point-of-use
NEW YORK, July 14 /PRNewswire-FirstCall/ -- Nephros, Inc. (Amex: NEP), a medical device company, announced today that it will be exhibiting its Dual Stage Ultrafilter products at the American Society for Healthcare Engineering (ASHE) Conference and Technical Exhibition in National Harbor, Maryland, July 20th-23rd, 2008. Building on the success of the Nephros online hemodiafiltration technology, the Nephros Dual Stage Ultrafilter (DSU) delivers water free of bacteria, viruses, fungi, and other biologically hazardous elements. The Company believes the DSU can be an important addition to the hospital's arsenal in addressing water-borne hospital acquired infection (HAI) risks, and therefore help to reduce infection-related hospital costs and liability associated with prolonged hospital stays, additional care requirements, and patient mortality.
HAIs of all types are a significant problem in the U.S. According to the Centers for Disease Control and Prevention (CDC), there are over 2 million HAIs annually in the U.S., resulting in an estimated $30.5 billion in additional healthcare costs and over 100,000 in-hospital deaths. The federal Medicare program recently announced that, beginning in October 2008, it will no longer pay extra costs associated with certain types of HAIs. A variety of pathogens survives and even thrives in hospital plumbing systems despite chemical and heat-based treatments designed to eradicate them.
"Hospitals and related healthcare settings recognize that water-borne
pathogens represent a substantial risk, and are taking measures to protect
their patient populations accordingly. We be
|SOURCE Nephros, Inc.|
Copyright©2008 PR Newswire.
All rights reserved